LIPKX vs. ECAT

Last updated Jun 4, 2026

LIPKX (BlackRock LifePath Index 2050 Fund Class K) and ECAT (BlackRock ESG Capital Allocation Term Trust) are both mutual funds - LIPKX is a Target Retirement Date fund tracking the BlackRock LifePath Index 2050 Custom Benchmark (USD), while ECAT is a Derivative Income fund managed by BlackRock. Over the past 3 years, LIPKX returned 19.17%/yr vs 19.24%/yr for ECAT. A 0.73 correlation means they provide meaningful diversification when combined. LIPKX charges 0.09%/yr vs 1.38%/yr for ECAT.

Performance

LIPKX vs. ECAT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in BlackRock LifePath Index 2050 Fund Class K (LIPKX) and BlackRock ESG Capital Allocation Term Trust (ECAT). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, LIPKX achieves a 12.50% return, which is significantly higher than ECAT's 11.23% return.

LIPKX

• 1D: 0.43%
• 1M: 5.32%
• YTD: 12.50%
• 6M: 13.26%
• 1Y: 28.65%
• 3Y*: 19.17%
• 5Y*: 10.07%
• 10Y*: 11.76%

ECAT

• 1D: -1.20%
• 1M: 6.84%
• YTD: 11.23%
• 6M: 9.37%
• 1Y: 20.83%
• 3Y*: 19.24%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

LIPKX vs. ECAT - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
LIPKX BlackRock LifePath Index 2050 Fund Class K	12.50%	20.71%	12.88%	21.38%	-18.34%	5.65%
ECAT BlackRock ESG Capital Allocation Term Trust	11.23%	16.64%	19.96%	32.36%	-21.90%	-6.25%

Correlation

The correlation between LIPKX and ECAT is 0.69, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.69
Correlation (3Y) Calculated over the trailing 3-year period	0.69
Correlation (All Time) Calculated using the full available price history since Sep 29, 2021	0.73

The correlation between LIPKX and ECAT has been stable across timeframes, ranging from 0.69 to 0.73 - a consistent structural relationship.

Return for Risk

LIPKX vs. ECAT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

LIPKX

LIPKX Risk / Return Rank: 68
LIPKX Sharpe Ratio Rank: 68
LIPKX Sortino Ratio Rank: 65
LIPKX Omega Ratio Rank: 62
LIPKX Calmar Ratio Rank: 68
LIPKX Martin Ratio Rank: 75

ECAT

ECAT Risk / Return Rank: 28
ECAT Sharpe Ratio Rank: 30
ECAT Sortino Ratio Rank: 29
ECAT Omega Ratio Rank: 29
ECAT Calmar Ratio Rank: 23
ECAT Martin Ratio Rank: 28

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

LIPKX vs. ECAT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for BlackRock LifePath Index 2050 Fund Class K (LIPKX) and BlackRock ESG Capital Allocation Term Trust (ECAT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	LIPKX	ECAT	Difference
Sharpe ratio Return per unit of total volatility	2.43	1.56	+0.87
Sortino ratio Return per unit of downside risk	3.37	2.22	+1.16
Omega ratio Gain probability vs. loss probability	1.44	1.28	+0.16
Calmar ratio Return relative to maximum drawdown	3.20	1.77	+1.42
Martin ratio Return relative to average drawdown	14.13	6.65	+7.47
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

LIPKX vs. ECAT - Sharpe Ratio Comparison

The current LIPKX Sharpe Ratio is 2.43, which is higher than the ECAT Sharpe Ratio of 1.56. The chart below compares the historical Sharpe Ratios of LIPKX and ECAT, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	LIPKX	ECAT	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	2.43	1.56	+0.87
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.65	—	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.71	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.62	0.55	+0.08

Drawdowns

LIPKX vs. ECAT - Drawdown Comparison

The maximum LIPKX drawdown since its inception was -34.29%, which is greater than ECAT's maximum drawdown of -32.23%. Use the drawdown chart below to compare losses from any high point for LIPKX and ECAT.

Drawdown Indicators

	LIPKX	ECAT	Difference
Max Drawdown Largest peak-to-trough decline	-34.29%	-32.23%	-2.06%
Max Drawdown (1Y) Largest decline over 1 year	-9.09%	-11.80%	+2.71%
Max Drawdown (3Y) Largest decline over 3 years	-17.06%	-15.79%	-1.27%
Max Drawdown (5Y) Largest decline over 5 years	-26.35%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-34.29%	—	—
Current Drawdown Current decline from peak	0.00%	-1.20%	+1.20%
Average Drawdown Average peak-to-trough decline	-4.51%	-9.11%	+4.60%
Ulcer Index Depth and duration of drawdowns from previous peaks	2.05%	3.14%	-1.09%

Volatility

LIPKX vs. ECAT - Volatility Comparison

BlackRock LifePath Index 2050 Fund Class K (LIPKX) has a higher volatility of 3.76% compared to BlackRock ESG Capital Allocation Term Trust (ECAT) at 3.31%. This indicates that LIPKX's price experiences larger fluctuations and is considered to be riskier than ECAT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	LIPKX	ECAT	Difference
Volatility (1M) Calculated over the trailing 1-month period	3.76%	3.31%	+0.45%
Volatility (6M) Calculated over the trailing 6-month period	9.63%	10.59%	-0.96%
Volatility (1Y) Calculated over the trailing 1-year period	11.99%	13.44%	-1.45%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	15.50%	16.90%	-1.40%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	16.51%	16.90%	-0.39%

LIPKX vs. ECAT - Expense Ratio Comparison

LIPKX has a 0.09% expense ratio, which is lower than ECAT's 1.38% expense ratio.

Dividends

LIPKX vs. ECAT - Dividend Comparison

LIPKX's dividend yield for the trailing twelve months is around 2.51%, less than ECAT's 21.71% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
ECAT BlackRock ESG Capital Allocation Term Trust	21.71%	23.00%	17.44%	9.14%	8.94%	0.54%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
LIPKX BlackRock LifePath Index 2050 Fund Class K	2.51%	2.82%	0.01%	2.14%	2.08%	2.20%	1.11%	3.33%	2.42%	2.36%	1.60%	3.17%

Frequently Asked Questions

Can I hold both LIPKX and ECAT in my portfolio?

LIPKX and ECAT have a correlation of 0.69, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, LIPKX or ECAT?

LIPKX has higher volatility (3.76%) compared to ECAT (3.31%). In terms of maximum drawdown, LIPKX dropped -34.29% vs ECAT's -32.23%.

Which has better risk-adjusted returns?

LIPKX currently has the higher Sharpe Ratio (2.42 vs 1.56), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.